EGFR and lung carcinoma: This can be explained by the fact that the lung cancer cases in the TCGA dataset include a heterogeneous mixture of mutations, with EGFR mutations likely comprising only a small subset and only a small subset of TCGA cases were treated with EGFR-TKIs.